Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

25.48
Delayed Data
As of 2:02pm ET
 0.00 / 0.00%
Today’s Change
21.84
Today|||52-Week Range
33.60
+1.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues152.4M183.6M244.8M289.0M
 
 
 
 
 
Cost of Goods Sold130.0M146.5M116.2M193.1M
 
 
 
 
 
Depreciation And Amortization3.6M6.0M7.1M9.5M
 
 
 
 
 
 
Operating ExpensesGross Income18.8M31.1M121.5M86.4M
 
 
 
 
 
General Expenses37.9M47.2M56.0M70.0M
 
 
 
 
 
Research And Development12.8M17.1M19.8M26.8M
 
 
 
 
 
Total Operating Expenses171.5M199.7M179.2M272.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.1M-16.1M65.5M16.3M
 
 
 
 
 
Extraordinary Credit0.000.007.9M0.00
 
 
Extraordinary Charge-838.0K-1.1M-44.5M-1.3M
 
 
 
 
 
Pre-Tax Equity Earnings-2.5M1.3M2.4M4.0M
 
 
 
 
 
Interest Expense On Debt4.2M1.2M930.0K2.2M
 
 
 
 
 
Other Expenses0.000.000.00-678.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.4M-16.8M30.5M16.2M
 
 
 
 
 
Income Taxes0.000.00-895.0K-23.7M
 
 
 
Net Income-26.4M-16.8M29.6M39.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.1M28.0M29.2M31.9M
 
 
 
 
 
Shares To Calculate EPS Diluted20.1M28.0M29.9M32.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.31-$0.60$0.99$1.22
 
 
 
 
 
EPS Diluted-$1.31-$0.60$0.99$1.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account